CORVUS PHARMACEUTICALS INC's ticker is CRVS and the CUSIP is 221015100. A total of 51 filers reported holding CORVUS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 3.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $57 | +119.2% | 39,493 | +242.6% | 0.00% | – |
| Q2 2023 | $26 | +44.4% | 11,529 | -46.2% | 0.00% | – |
| Q4 2022 | $18 | -99.9% | 21,419 | +33.5% | 0.00% | – |
| Q3 2022 | $13,000 | -48.0% | 16,050 | -37.3% | 0.00% | – |
| Q2 2022 | $25,000 | -21.9% | 25,598 | +27.5% | 0.00% | – |
| Q1 2022 | $32,000 | – | 20,074 | +9987.4% | 0.00% | – |
| Q3 2021 | $0 | – | 199 | 0.0% | 0.00% | – |
| Q2 2021 | $0 | -100.0% | 199 | -96.6% | 0.00% | – |
| Q1 2021 | $18,000 | – | 5,886 | +4930.8% | 0.00% | – |
| Q3 2020 | $0 | – | 117 | -19.9% | 0.00% | – |
| Q1 2020 | $0 | – | 146 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ADAMS STREET PARTNERS LLC | 3,275,616 | $8,746,000 | 1.82% |
| Telemetry Investments, L.L.C. | 263,975 | $705,000 | 0.97% |
| CHI Advisors LLC | 719,132 | $1,920,000 | 0.45% |
| BVF INC/IL | 3,678,626 | $9,822,000 | 0.37% |
| EcoR1 Capital, LLC | 3,579,377 | $9,557,000 | 0.36% |
| Orbimed Advisors | 8,053,298 | $21,502,000 | 0.22% |
| Stonepine Capital Management, LLC | 46,886 | $125,000 | 0.06% |
| Ikarian Capital, LLC | 100,000 | $267,000 | 0.02% |
| ALGERT GLOBAL LLC | 19,737 | $53,000 | 0.02% |
| Windsor Creek Advisors, LLC | 14,786 | $39,000 | 0.01% |